Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk
- 10 July 2009
- journal article
- Published by Springer Nature in Diabetologia
- Vol. 52 (9), 1881-1888
- https://doi.org/10.1007/s00125-009-1438-0
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- A Common Nonsynonymous Single Nucleotide Polymorphism in the SLC30A8 Gene Determines ZnT8 Autoantibody Specificity in Type 1 DiabetesDiabetes, 2008
- SLC30A8 (ZnT8) Polymorphism is Associated with Young Age at Type 1 Diabetes OnsetThe Review of Diabetic Studies, 2008
- The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetesProceedings of the National Academy of Sciences, 2007
- A Genome-Wide Association Study of Type 2 Diabetes in Finns Detects Multiple Susceptibility VariantsScience, 2007
- GAD Autoantibody Affinity and Epitope Specificity Identify Distinct Immunization Profiles in Children at Risk for Type 1 DiabetesDiabetes, 2007
- A genome-wide association study identifies novel risk loci for type 2 diabetesNature, 2007
- Predicting type 1 diabetesCurrent Diabetes Reports, 2005
- Islet autoimmunity in infants with a Type I diabetic relative is common but is frequently restricted to one autoantibodyDiabetologia, 2000
- IA-2 and IA-2β: the immune response in IDDMDiabetes/Metabolism Research and Reviews, 1998
- A Mathematical Model for the Determination of Total Area Under Glucose Tolerance and Other Metabolic CurvesDiabetes Care, 1994